Clinical Trials Directory

Trials / Completed

CompletedNCT00692731

Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss

A Randomized, Double-Blind, Controlled Study to Assess the Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss

Status
Completed
Phase
Study type
Observational
Enrollment
132 (actual)
Sponsor
Provident Clinical Research · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

The primary objective of this trial is to evaluate the influence of consuming a tea catechin containing sports beverage on body fat mass during exercise-induced weight loss among overweight and obese men and women.

Detailed description

The study will include two screening/baseline visits and six treatment visits over 12 weeks. During the treatment phase of the study, subjects will be instructed to consume one bottle of sports drink (500 ml) daily (total consumption of tea catechins in the active group = 540 mg/d). Subjects will be asked to maintain a constant energy intake throughout the study period. Three-day diet records will be collected and analyzed at weeks 0, 6, and 12 to evaluate consistency of energy intake. All subjects will engage in an exercise program with a goal of maintaining 180 min/week of low- to moderate-intensity exercise (e.g., walking and other aerobic activities, 4-6 days per week). Three of the weekly exercise sessions will be supervised and 1-3 will be unsupervised. Subjects will be asked to wear a pedometer and record their daily physical activity (steps) each night in a physical activity diary. Diaries will be collected at each visit and used to evaluate exercise compliance. Dual energy X-ray absorptiometry (DEXA) and computed tomography (CT) scans will be performed at baseline (week 0) and at the end of the treatment (week 12). Additionally, body weight and abdominal circumference will be assessed at every clinic visit during the study. It is anticipated that subjects will expend 1000-1800 kcal per week above their baseline level in deliberate physical activity. Accordingly, the control group is expected to lose 1.5 to 2.8 kg of body fat during the 12-week treatment period

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT500 mL/day of a beverage providing approximately 625 mg catechinsSubjects were asked to consume 500 mL/day of a beverage providing approximately 625 mg catechins
OTHERControl beverage matched for energy and caffeine content500 mL/day of a control beverage

Timeline

Start date
2006-06-01
Primary completion
2007-07-01
Completion
2007-08-01
First posted
2008-06-06
Last updated
2008-06-06

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00692731. Inclusion in this directory is not an endorsement.